BRAF and neoplasm: In addition, given the observational nature of this study, differences in TFS between groups may also be partially associated with underlying differences in key clinical variables, such as ECOG status and patient age, as well as differences in tumor characteristics, such as the proportion of BRAF V600E–positive patients, which were not accounted for in this analysis.